Historical record - last NADAC publication: 2/22/2017

Product Information

RAMIPRIL 1.25 MG CAPSULE is a generic product labeled by Aurobindo Pharma Limited, priced at $0.1792 per EA under NDC 65862047430. Its NADAC has been published 170 times since Nov 28, 2013.

The High Outlier badge above means this manufacturer's average price in the Ramipril market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

RAMIPRIL 1.25 MG CAPSULE

Ramipril
$0.1792per EA
High Outlier

Strength

1.25 mg/1

NDC

65862047430

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Last Updated

2/22/2017

Active Ingredients

RAMIPRIL

Approval Type

Generic (ANDA)

FDA Application

ANDA091604

On Market Since

6/8/2011

Pharmacological Classes

Angiotensin Converting Enzyme Inhibitor
Angiotensin-converting Enzyme Inhibitors

Price Statistics

The NADAC for RAMIPRIL 1.25 MG CAPSULE has been published 170 times since Nov 28, 2013, and over the history we have for it it has declined 15.6%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1792 per EA
All-time high$0.2323 (Aug 13, 2014)
All-time low$0.1542 (Jan 18, 2017)
Median price$0.1970
Average price$0.1957
Largest weekly change+33.5% (Jan 20, 2016)
Weeks tracked170
Tracking sinceNov 28, 2013

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

0.0%

5Y

0.0%

All

-15.6%

Generic Alternatives

The matcher finds 7 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 7 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 52% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of RAMIPRIL 1.25 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for RAMIPRIL 1.25 MG CAPSULE, manufactured by Aurobindo Pharma Limited, is $0.1792 per EA (NDC 65862047430), effective Feb 22, 2017.

How has the price of RAMIPRIL 1.25 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for RAMIPRIL 1.25 MG CAPSULE has declined 15.6%. It has been tracked across 170 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for RAMIPRIL 1.25 MG CAPSULE?

Since Nov 28, 2013, the NADAC for RAMIPRIL 1.25 MG CAPSULE has ranged from a low of $0.1542 (Jan 18, 2017) to a high of $0.2323 (Aug 13, 2014), with a median of $0.1970 per EA.

Are there cheaper alternatives to RAMIPRIL 1.25 MG CAPSULE?

Yes. 7 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, RAMIPRIL 1.25 MG CAPSULE, is $0.0867 per EA — about 52% below RAMIPRIL 1.25 MG CAPSULE.

Who manufactures RAMIPRIL 1.25 MG CAPSULE?

RAMIPRIL 1.25 MG CAPSULE (NDC 65862047430) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.